Pulmonary edema induced by phorbol myristate acetate is attenuated by compounds that increase intracellular cAMP
- PMID: 8833484
- DOI: 10.1007/BF02576825
Pulmonary edema induced by phorbol myristate acetate is attenuated by compounds that increase intracellular cAMP
Abstract
We have investigated the effect of terbutaline, aminophylline and dibutyryl cyclic AMP (DBcAMP) on phorbol myristate acetate (PMA)-induced acute lung injury in isolated, blood-perfused rabbit lungs. Pulmonary arterial pressure and lung weight were measured for 30 min after a bolus injection of PMA (10 mu g/kg). In the group exposed to PMA alone, the mean pulmonary arterial pressure (PAP) increased from 16.33 + or - 1.28 to 77.30 + or - 6.40 mmHg (P <0.001), and lung weight increased by 70.69 + or - 10.94 g during the 30 min after PMA challenge (P<0.001). Pretreatment with terbutaline, aminophylline or DBcAMP prevented the increases in both PAP and lung weight (P <0.001). Each of the three drugs also prevented the increase in pulmonary vascular permeability induced by PMA: terbutaline, aminophylline, and DBcAMP all significantly reduced the pulmonary capillary filtration coefficient (KfC) as well as the albumin concentration in the lung lavage fluid after PMA exposure. Post-treatment with terbutaline 5 min after PMA administration also had a protective effect. The mechanisms responsible for these protectivp3 effects may all involve an increase in intracellular cAMP, since all three drugs increase cAMP in the lung (though by different mechanisms). Our data further indicate that the inhibition of tumor necrosis factor production may likewise play an important role in the protective effect exerted by these drugs.
Similar articles
-
Dibutyryl cAMP, aminophylline, and beta-adrenergic agonists protect against pulmonary edema caused by phosgene.J Appl Physiol (1985). 1989 Dec;67(6):2542-52. doi: 10.1152/jappl.1989.67.6.2542. J Appl Physiol (1985). 1989. PMID: 2558103
-
N-acetylcysteine attenuates the acute lung injury caused by phorbol myristate acetate in isolated rat lungs.Pulm Pharmacol Ther. 2007;20(6):726-33. doi: 10.1016/j.pupt.2006.08.010. Epub 2006 Sep 19. Pulm Pharmacol Ther. 2007. PMID: 17071120
-
The protective effect of mepacrine on acute lung edema induced by phorbol myristate acetate in rats.Chin J Physiol. 1990;33(4):301-14. Chin J Physiol. 1990. PMID: 2097100
-
Therapeutic treatments of phosgene-induced lung injury.Inhal Toxicol. 2004 Jul;16(8):565-80. doi: 10.1080/08958370490442584. Inhal Toxicol. 2004. PMID: 15204747 Review.
-
Mitigation of chlorine lung injury by increasing cyclic AMP levels.Proc Am Thorac Soc. 2010 Jul;7(4):284-9. doi: 10.1513/pats.201001-002SM. Proc Am Thorac Soc. 2010. PMID: 20601633 Free PMC article. Review.
Cited by
-
Acute respiratory distress syndrome and lung injury: Pathogenetic mechanism and therapeutic implication.World J Crit Care Med. 2012 Apr 4;1(2):50-60. doi: 10.5492/wjccm.v1.i2.50. eCollection 2012 Apr 4. World J Crit Care Med. 2012. PMID: 24701402 Free PMC article. Review.
-
Aminophylline modulates the permeability of endothelial cells via the Slit2-Robo4 pathway in lipopolysaccharide-induced inflammation.Exp Ther Med. 2021 Sep;22(3):1042. doi: 10.3892/etm.2021.10474. Epub 2021 Jul 21. Exp Ther Med. 2021. PMID: 34373728 Free PMC article.
-
Acute respiratory distress syndrome.J Biomed Sci. 2003;10(6 Pt 1):588-92. doi: 10.1159/000073523. J Biomed Sci. 2003. PMID: 14576460 Free PMC article. Review.
-
Phosphodiesterase Inhibitors in Acute Lung Injury: What Are the Perspectives?Int J Mol Sci. 2021 Feb 16;22(4):1929. doi: 10.3390/ijms22041929. Int J Mol Sci. 2021. PMID: 33669167 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials